谷歌浏览器插件
订阅小程序
在清言上使用

A multicenter investigator-initiated Phase 2 trial of E7090 in patients with advanced or recurrent solid tumor with fibroblast growth factor receptor ( FGFR ) gene alteration: FORTUNE trial

BMC Cancer(2022)

引用 4|浏览23
暂无评分
关键词
Fibroblast growth factor receptor, Gene fusion, Mutation, Amplification, Precision medicine
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要